Biogen Idec Inc $339.97

up +1.32


22/8/2014 04:00 PM  |  NASDAQ : BIIB  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get BIIB Trend Analysis - it has outperformed the S&P 500 by 41%

Partner Headlines

  1. Majority Of IBD 50 Firms Strong On Sponsorship

    IBD
  2. Biogen's buy rating reaffirmed

    IBD
  3. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy Approval

    Benzinga
  4. Perrigo Regains Some Lost Ground On Fiscal Q4 Beat

    IBD
  5. Perrigo Q4 Beats Estimates, But Guidance Misses

    IBD
  6. Tech, Health Care Lead Q2 Earnings Beats

    IBD
  7. #PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq

    Benzinga
  8. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  9. Why Investors Should Closely Watch Celgene

    Benzinga
  10. Biotech Gets A Lift On Popular Drug, Strong Pipeline

    IBD
  11. Ken Fisher's Top Increaes of the Second Quarter

    GuruFocus
  12. Ken Fisher's Top Increases of the Second Quarter

    GuruFocus
  13. Chipotle, Facebook Rally On Upside Earnings Surprise

    IBD
  14. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  15. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  16. Biogen, Gilead Profits Soar

    IBD
  17. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  18. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  19. IPO Stock Watch: Biotechs Are Half Of July Calendar

    IBD
  20. Vertex Is Poised For An Earnings Breakout

    Benzinga
  21. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  22. S&P 500 Flirts With High; Breadth Missing On Nasdaq

    IBD
  23. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  24. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  25. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  26. Apple, Microsoft Lead Nasdaq Higher; Dow Falters

    IBD
  27. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  28. Stocks: Mixed Open, Mixed Trade; Delta, Broadcom, Biogen Buck Up

    IBD
  29. Morning Market Movers

    Benzinga
  30. UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, Shares Surge

    Benzinga
  31. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  32. Benzinga's Top #PreMarket Gainers

    Benzinga
  33. Earnings Scheduled For July 23, 2014

    Benzinga
  34. Stocks Rise; Apple, Microsoft Steady In Post-Session

    IBD
  35. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  36. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  37. Oil Dominates; Keurig, Constellation Near Buy Points

    IBD
  38. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  39. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  40. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  41. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  42. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  43. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  44. IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market

    IBD
  45. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  46. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  47. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
  48. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  49. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  50. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
Trading Center